NCT00889720View on ClinicalTrials.gov

A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Smoking Cessation
Interventions
DRUG

Varenicline

Varenicline film coated tablets - escalating dose with maximum dose of 1mg bd

Trial Locations (2)

56124

Pfizer Investigational Site, Pisa

75651

Pfizer Investigational Site, Paris

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00889720 - A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery | Biotech Hunter | Biotech Hunter